Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research episode artwork

EPISODE · Feb 3, 2021 · 12 MIN

Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research

from Drug Safety Matters · host Uppsala Monitoring Centre

Send us a voicemail!As the cradle of modern humanity, the African continent is home to populations with high levels of genetic diversity. But while this diversity has implications for the safety and efficacy of many drugs, African patients remain underrepresented in drug studies. In fact, while more than 400 medicines have pharmacogenetics information and public guidelines available, only 15 have been studied in African populations. Thankfully efforts to boost pharmacogenomics research in Africa are now underway.This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.Tune in to find out:How drug metabolism is affected by genetic variationWhy African patients urgently need genotype-guided drug dosing How different research initiatives are trying to fill the knowledge gapWant to know more?A review of the disease burden in Africa concluded that a pharmacogenomics-based healthcare approach – where drug choices and doses are optimised for each patient ­– would benefit the genetically diverse African population.Clinical pharmacogenetics studies conducted in African populations have so far highlighted several pharmacogenetics associations ­– but also gaps in knowledge.The African Pharmacogenomics Consortium drives pharmacogenomics research in Africa and aims to improve the safety of drugs for use in African populations.The Global Alliance for Genomics and Health aims to enable the safe and effective sharing of genomic and health-related data between different research and healthcare institutions.Finally, don’t forget to ­subscribe to the monthly Uppsala Reports newsletter for free regular updates from the world of pharmacovigilance.Got a story to share?We’re always looking for new topics and interesting voices. If you have an idea or any other feedback for the show, get in touch!About UMCUppsala Monitoring Centre promotes safer use of medicines and vaccines for everyone everywhere. Follow us on Facebook, LinkedIn, X, and Bluesky.

Episode metadata supplied by the publisher feed · Published Feb 3, 2021

Embed this episode

Send us a voicemail! As the cradle of modern humanity, the African continent is home to populations with high levels of genetic diversity. But while this diversity has implications for the safety and efficacy of many drugs, African patients remain underrepresented in drug studies. In fact, while more than 400 medicines have pharmacogenetics information and public guidelines available, only 15 have been studied in African populations. Thankfully efforts to boost pharmacogenomics research in Af...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research

0:00 12:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Drug Safety Matters?

This episode is 12 minutes long.

When was this Drug Safety Matters episode published?

This episode was published on February 3, 2021.

Can I download this Drug Safety Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!